Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 22, 2024 08:05 ET
GOGL – Q1 2024 Presentation
Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2024 results for today’s webcast / conference call at 15:00 CEST. Attend by Webcast: Use the follow link prior to the webcast: GOGL Q1 2024 Webcast...
May 22, 2024 08:05 ET
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and innovative...
May 22, 2024 08:02 ET
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Michael Raab, President and...
May 22, 2024 08:02 ET
Tricolor Issues $277M Social Bond to Support Physical Mobility and Expand Financial Inclusion in Underserved Hispanic Communities
Tricolor today announced its fourth social bond, a $277 million issuance to empower underserved, low-income Hispanic communities with access to affordable financing for their vital transportation needs that ultimately unlocks a path to mainstream...
May 22, 2024 08:01 ET
CDT Environmental Technology Investment Holdings Limited Establishes Partnership with Fortune 500 Company's Subsidiary to Jointly Bid for Large-Scale Sewage Treatment Facility in Hengqin, China
CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) ("CDT"), a leading provider of waste treatment systems and services throughout China, announces the formation of a consortium with a wholly-owned subsidiary of a Fortune Global...
May 22, 2024 08:01 ET
Liberty Military Housing Named Among Best Places to Work in Commercial Real Estate by Globe St.
Newport Beach, CA – Liberty Military Housing (Liberty), an employee-owned housing provider, today announced that it has been named among the Best Places to Work in Commercial Real Estate by Globe St. Real Estate Forum. This prestigious honor...
May 22, 2024 08:00 ET
Mersana Therapeutics to Present at Upcoming Investor Conferences
Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that...
May 22, 2024 08:00 ET
OPTIZMO™ Partners as Official Content Sponsor for LinkUnite IV
OPTIZMO Technologies, the leading platform for email suppression list management, data security, and email compliance, proudly announces its partnership with LinkUnite as the official content sponsor for the annual event. As one of the...
May 22, 2024 08:00 ET
ABM to Announce Second Quarter 2024 Financial Results
ABM (NYSE: ABM), a leading provider of facility solutions, today announced that it will release its financial results for the Company’s fiscal second quarter 2024 on Thursday, June 6, 2024, before market open. ABM will host its quarterly...
May 22, 2024 08:00 ET
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, recently announced that the first patient was dosed in the Phase II clinical trial...
May 22, 2024 08:00 ET
Alignment Healthcare to Present at William Blair's 44th Annual Growth Stock Conference
Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will present at William Blair's 44th Annual Growth Stock Conference in Chicago on Wednesday, June 5, at 12:40...
May 22, 2024 08:00 ET
All resolutions approved at the 2024 STMicroelectronics' Annual General Meeting of Shareholders
All resolutions approved at the 2024 STMicroelectronics' Annual General Meeting of Shareholders Amsterdam, May 22, 2024 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics...
May 22, 2024 08:00 ET
Arctic Semiconductor Announces 3GPP Compliant Platform for 5G Private Networks Featuring Products from Skyworks and Synergy
Arctic Semiconductor, a pioneer in low-power, versatile RF, and mixed-signal chipsets, today announced that its low power, high performance 4x4 transceiver IceWings is powering a new small cell platform that has passed 3GPP specification and will...
May 22, 2024 08:00 ET
Arq Publishes its Inaugural ESG Overview
Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced the publication of its inaugural Environmental,...
May 22, 2024 08:00 ET
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will present data from its herpes simplex virus (HSV) and hepatitis D virus...
May 22, 2024 08:00 ET
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today it will present 11 posters, and one oral presentation, supporting the use of LUMRYZ as a narcolepsy treatment option at SLEEP...
May 22, 2024 08:00 ET
Avatier Identity & Access Management for IBM i (Formerly iSeries) Environments
Avatier, a leading provider of identity management solutions, is proud to announce its integration with IBM Power Servers (formerly AS/400) to deliver a groundbreaking identity management experience for IBM i environments. This collaboration brings...
May 22, 2024 08:00 ET
Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024
Barinthus Biotherapeutics plc (NASDAQ: BRNS) (the Company), a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity...
May 22, 2024 08:00 ET
BioVie’s Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced data from an oral...
May 22, 2024 08:00 ET
Bluejay Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver (EASL) Congress 2024
Bluejay Therapeutics today announced it will present new data from its ongoing Phase 2 trial evaluating the potential of BJT-778, an investigational anti-HBsAg monoclonal antibody (mAb) that acts against hepatitis B surface antigen, for the...